Seneca Partners — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Oxford Biodynamicsoxfordbiodynamics.com in 𝕏Oct 2021

Oxford BioDynamics develops precision clinical diagnostic blood tests for detecting cancer and predicting treatment response in cancer patients, using its proprietary 3D genomic biomarker platform.

BiotechDigital HealthMedical DevicesOxford, GB

Alexandre Akoulitchev(Director)Jon Burrows(Chief Executive Officer)Paul Stockdale(Chief Financial Officer)

Board Stephen Diggle(Director)inDavid Holbrook(Director)Matthew Wakefield(Director)

Co-investorsVulpes Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.